Compound Detail
CHEMBL334895
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL334895 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ADKMDGCSIOZQIC-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
367.8
MW (Da)
3.06
ALogP
5
HBA
0
HBD
81.5
PSA (Ų)
0.78
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.61
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MT4 CHEMBL388 | EC50 | 4.61 | 4.61 | 24500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | EC50 | = | 24500.0 | nM | 4.61 | Dose required to achieve 50% protection of MT-4 cells from HIV-1(IIIB) induced c... | 9767646 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 9767646 | 10.1021/jm9802012 | MT4 | 2 |
| 9767646 | 10.1021/jm9802012 | Human immunodeficiency virus 1 | 1 |
Data from ChEMBL 36 via Core Engine